Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.
The effect of local and systemic injections of mesenchymal stem cells derived from adipose tissue (AD-MSC) into rabbit models of corneal allograft rejection with either normal-risk or high-risk vascularized corneal beds was investigated. The models we present in this study are more similar to human...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117945&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850023217660428288 |
|---|---|
| author | Sherezade Fuentes-Julián Francisco Arnalich-Montiel Laia Jaumandreu Marina Leal Alfonso Casado Ignacio García-Tuñon Enrique Hernández-Jiménez Eduardo López-Collazo Maria P De Miguel |
| author_facet | Sherezade Fuentes-Julián Francisco Arnalich-Montiel Laia Jaumandreu Marina Leal Alfonso Casado Ignacio García-Tuñon Enrique Hernández-Jiménez Eduardo López-Collazo Maria P De Miguel |
| author_sort | Sherezade Fuentes-Julián |
| collection | DOAJ |
| description | The effect of local and systemic injections of mesenchymal stem cells derived from adipose tissue (AD-MSC) into rabbit models of corneal allograft rejection with either normal-risk or high-risk vascularized corneal beds was investigated. The models we present in this study are more similar to human corneal transplants than previously reported murine models. Our aim was to prevent transplant rejection and increase the length of graft survival. In the normal-risk transplant model, in contrast to our expectations, the injection of AD-MSC into the graft junction during surgery resulted in the induction of increased signs of inflammation such as corneal edema with increased thickness, and a higher level of infiltration of leukocytes. This process led to a lower survival of the graft compared with the sham-treated corneal transplants. In the high-risk transplant model, in which immune ocular privilege was undermined by the induction of neovascularization prior to graft surgery, we found the use of systemic rabbit AD-MSCs prior to surgery, during surgery, and at various time points after surgery resulted in a shorter survival of the graft compared with the non-treated corneal grafts. Based on our results, local or systemic treatment with AD-MSCs to prevent corneal rejection in rabbit corneal models at normal or high risk of rejection does not increase survival but rather can increase inflammation and neovascularization and break the innate ocular immune privilege. This result can be partially explained by the immunomarkers, lack of immunosuppressive ability and immunophenotypical secretion molecules characterization of AD-MSC used in this study. Parameters including the risk of rejection, the inflammatory/vascularization environment, the cell source, the time of injection, the immunosuppression, the number of cells, and the mode of delivery must be established before translating the possible benefits of the use of MSCs in corneal transplants to clinical practice. |
| format | Article |
| id | doaj-art-57f03104c94942f1a4dcdbebf3f148f2 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-57f03104c94942f1a4dcdbebf3f148f22025-08-20T03:01:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011794510.1371/journal.pone.0117945Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.Sherezade Fuentes-JuliánFrancisco Arnalich-MontielLaia JaumandreuMarina LealAlfonso CasadoIgnacio García-TuñonEnrique Hernández-JiménezEduardo López-CollazoMaria P De MiguelThe effect of local and systemic injections of mesenchymal stem cells derived from adipose tissue (AD-MSC) into rabbit models of corneal allograft rejection with either normal-risk or high-risk vascularized corneal beds was investigated. The models we present in this study are more similar to human corneal transplants than previously reported murine models. Our aim was to prevent transplant rejection and increase the length of graft survival. In the normal-risk transplant model, in contrast to our expectations, the injection of AD-MSC into the graft junction during surgery resulted in the induction of increased signs of inflammation such as corneal edema with increased thickness, and a higher level of infiltration of leukocytes. This process led to a lower survival of the graft compared with the sham-treated corneal transplants. In the high-risk transplant model, in which immune ocular privilege was undermined by the induction of neovascularization prior to graft surgery, we found the use of systemic rabbit AD-MSCs prior to surgery, during surgery, and at various time points after surgery resulted in a shorter survival of the graft compared with the non-treated corneal grafts. Based on our results, local or systemic treatment with AD-MSCs to prevent corneal rejection in rabbit corneal models at normal or high risk of rejection does not increase survival but rather can increase inflammation and neovascularization and break the innate ocular immune privilege. This result can be partially explained by the immunomarkers, lack of immunosuppressive ability and immunophenotypical secretion molecules characterization of AD-MSC used in this study. Parameters including the risk of rejection, the inflammatory/vascularization environment, the cell source, the time of injection, the immunosuppression, the number of cells, and the mode of delivery must be established before translating the possible benefits of the use of MSCs in corneal transplants to clinical practice.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117945&type=printable |
| spellingShingle | Sherezade Fuentes-Julián Francisco Arnalich-Montiel Laia Jaumandreu Marina Leal Alfonso Casado Ignacio García-Tuñon Enrique Hernández-Jiménez Eduardo López-Collazo Maria P De Miguel Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome. PLoS ONE |
| title | Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome. |
| title_full | Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome. |
| title_fullStr | Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome. |
| title_full_unstemmed | Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome. |
| title_short | Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome. |
| title_sort | adipose derived mesenchymal stem cell administration does not improve corneal graft survival outcome |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117945&type=printable |
| work_keys_str_mv | AT sherezadefuentesjulian adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome AT franciscoarnalichmontiel adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome AT laiajaumandreu adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome AT marinaleal adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome AT alfonsocasado adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome AT ignaciogarciatunon adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome AT enriquehernandezjimenez adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome AT eduardolopezcollazo adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome AT mariapdemiguel adiposederivedmesenchymalstemcelladministrationdoesnotimprovecornealgraftsurvivaloutcome |